Indicatori diversi, concordi nella valutazione dell'efficacia di omalizumab

Translated title of the contribution: Different indicators, univocous in the efficacy evaluation of omalizumab

E. Roma, P. Banfi

Research output: Contribution to journalArticle

Abstract

Some new papers coming from different Authors are here published, all yet concord in evaluating as excellent the effectiveness of Omalizumab in "difficult" allergic asthmatics. As in a few of the previous articles on Omalizumab published in the most recent issues of this Journal, some of the following case reports are characterized by the application of original evaluation criteria, all concord in defining the efficacy of the drug in treated patients.

Translated title of the contributionDifferent indicators, univocous in the efficacy evaluation of omalizumab
Original languageItalian
Pages (from-to)209-212
Number of pages4
JournalGIMT - Giornale Italiano delle Malattie del Torace
Volume61
Issue number3
Publication statusPublished - 2007

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Different indicators, univocous in the efficacy evaluation of omalizumab'. Together they form a unique fingerprint.

  • Cite this